drugset / Trial / NCT00619164
A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of E5555 in Japanese patients with acute coronary syndrome.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atopaxar | Small molecule | 50 mg | Oral |
| Subject | Atopaxar | Small molecule | 100 mg | Oral |
| Subject | Atopaxar | Small molecule | 200 mg | Oral |